[ Price : $8.95]
Federal Register Notice: FDA proposes to amend its regulations to add three drugs to the list of drug products that have been with...[ Price : $8.95]
Federal Register Final Order: FDA classifies as Class 2 (special controls) the upper extremity prosthesis including a simultaneous...[ Price : $8.95]
Federal Register proposed rule: FDA proposes to implement provisions requiring electronic submission of the device label and packa...[ Price : $8.95]
Federal Register Final Order: FDA classifies the apical closure device into Class 2 (special controls).[ Price : $8.95]
President Obamas Cancer Moonshot initiative releases a task force report on implementation plans.[ Price : $8.95]
FDA clears a Teleflex 510(k) to market its Arrow Midline with Chlorag+ard Technology, an anti-thrombogenic and antimicrobial perip...[ Price : $8.95]
Sandoz petitions FDA asking that it not approve generic copies of GlaxoSmithKlines asthma inhaler Advair Diskus 100/50 unless ANDA...[ Price : $8.95]
FDA reviewers question clinical trial designs in a Serenity Pharmaceuticals NDA for SER120 (desmopressin nasal spray), which is pr...